JAMES FLYNN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

MEI Pharma, Inc.

Filing Date Source Excerpt
2023-11-08 Mr. Flynn is currently a Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. He earned a S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from MIT.
2024-12-20 Mr. Flynn earned a S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from the Massachusetts Institute of Technology. We believe that Mr. Flynn is qualified to serve on the Board based on his business experience in the pharmaceutical industry and his business development experience.

Oruka Therapeutics, Inc.

Filing Date Source Excerpt
2022-11-03 Mr. Flynn, age 42, if elected, would be a member of the Board of Directors effective as of the 2022 Annual Meeting. ... Mr. Flynn is currently a Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. ... Mr. Flynn also currently serves as a Board Member for Axiom Health, a provider of software and big-data solutions to the healthcare industry, since 2022, and has been an advisor to the company since 2020. ... We believe Mr. Flynn is an appropriate member of the Board of Directors because of his experience as an investor in life sciences companies, an analyst for investment firms and his academic background.
2023-12-19 Mr. Flynn, age 43, has served as a member of the Board of Directors since December 2022. ... He serves on the Special Committee. Director compensation for 2022 was $24,680.

Data sourced from SEC filings. Last updated: 2026-02-03